OOIR: Observatory of International Research

Papers

(The TQCC of Current Opinion in Nephrology and Hypertension is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)

Article	Citations
Dual organ transplantation: Pancreas and Liver in the kidney axis	53
Emerging strategies to reduce kidney function decline and improve cardiovascular outcomes	38
Does cooled dialysate still have a role in reducing intradialytic stress? Implications of the MyTEMP trial	37
Editorial introductions	37
The impact of conflicts on patients with chronic kidney disease	35
Microvascular inflammation in the kidney transplant, beyond acute antibody-mediated rejection	24
Population Health Strategies for Health Equity in Chronic Kidney Disease Management: Retraction	22
Effect of the allelic background on the phenotype of primary hyperoxaluria type I	22
Barriers to home dialysis and kidney transplantation for socially disadvantaged individuals	21
Maximizing opportunities for kidney transplantation in older adults	20
Tackling the intersectoral challenges in kidney diseases and transplantation: shared decision and realistic care for advanced diagnostic and therapeutic modalities for kidney diseases and transplantat	20
Evolution in the targets for blood pressure treatment	19
Interferon gamma in the pathogenesis of hypertension − recent insights	19
Renal denervation for the treatment of hypertension and kidney disease	17
Editorial introduction	17
Modern indications for referral for kidney and pancreas transplantation	16
International equity in access to home dialysis	15
Safety of SGLT2i with regard to bone and mineral metabolism in patients with CKD	15
Prediction models for earlier stages of chronic kidney disease	15
Has the time come for age-adapted glomerular filtration rate criteria to define chronic kidney disease: how soon is now?	15
Skeletal parathyroid hormone hyporesponsiveness: a neglected, but clinically relevant reality in chronic kidney disease	14
Recent advances in peritoneal dialysis catheter placement: the association between method of insertion, operator, and prior abdominal surgery and outcomes	14
Editorial: The evolution of my personal conflict of interest: I am part of an ‘ineligible company’	14
Dialysis initiation for patients with decompensated cirrhosis when liver transplant is unlikely	14
Built environment and chronic kidney disease: current state and future directions	13

Updates in tolerance: future directions to improve kidney allograft survival	13
Bringing the end-stage kidney disease life plan home	13
Plant-based diets for kidney disease prevention and treatment	12
Calcium phosphate microcrystallopathy as a paradigm of chronic kidney disease progression	12
The race coefficient in glomerular filtration rate-estimating equations and its removal	12
Hypertension guidelines need to be patient oriented	12
Calcium-binding protein 39 in with-no-lysine kinase signaling and the modulation of renal tubular transport	12
Staying home when peritoneal dialysis ends: the integrated home dialysis approach	12
A basic solution for a complex problem: does treatment of metabolic acidosis slow CKD progression?	11
Recent insights into the role of dietary phosphorus in the development and progression of chronic kidney disease–mineral and bone disorder	11
Editorial: One size does not fit all: moving toward individualized therapy	11
Which patients with CKD will benefit from genomic sequencing? Synthesizing progress to illuminate the future	11
Synergistic susceptibility to environmental lead toxicity in chronic kidney disease	11
Bringing medical education “home”: the university health network and St. Michael's hospital home dialysis fellowship	11
Complement detection in kidney biopsies – utility and challenges	11
Editorial introductions	10
Understanding renal phosphate handling: unfinished business	10
WNK1 is a central osmolality sensor that regulates arginine vasopressin secretion	10
Stopping renin–angiotensin–aldosterone system inhibitors in kidney disease	10
Combination therapy with kidney protective therapies: optimizing the benefits?	10
Kidney care for children: their needs are different	10
Renal effects of cullin 3 mutations causing familial hyperkalemic hypertension	9
When the earth shakes unexpectedly: impact on nephrology services and patients	9
A current update of the development of Chimeric Antigen Receptor T-cell therapy and kidney disease	9
A guide for program development of environmentally sustainable kidney care	9
Editorial: Advancements in the management of kidney disease and electrolyte derangements	9
Paracellular transport along the nephron in physiology and pathophysiology	9
New advances in the diagnosis and pathologic spectrum of monoclonal gammopathy of renal significance	9
Dietary protein intake and plant-dominant diets to mitigate risk of allograft dysfunction progression in kidney transplant recipients	9
Editorial introductions	9
Impact of intensive blood pressure control on kidney outcomes	8
The current therapeutic approach for anaemia after kidney transplant	8
Deep learning applications for kidney histology analysis	8
Editorial: Innovations in multimodal and integrated approaches in kidney care and renal transplantation	8
Update on antineutrophil cytoplasmic antibody vasculitis: Erratum	8
Climate change and kidney stones	8
Recent updates in kidney risk prediction modeling: novel approaches and earlier outcomes	8
Cancer drugs and acute kidney injury: new therapies and new challenges	8
Mitochondrial bioenergetics: coupling of transport to tubular mitochondrial metabolism	8
Glucagon-like peptide-1 receptor agonists to improve cardiorenal outcomes: data from FLOW and beyond	8
Automation and innovation in home hemodialysis machines	8
Evolving thresholds for the diagnosis of acute T cell mediated rejection	7
Renal osteodystrophy: something old, something new, something needed	7
New insights into renal calcium-sensing receptor activation	7
Prospects for gene therapy in polycystic kidney disease	7
Editorial introductions	7
Novel therapeutic approaches for phosphate regulation	7
C3 glomerulopathy: advancements in diagnostics and therapeutics	7
Editorial introductions	7
Sex differences in renal electrolyte transport	7

Editorial introductions	7
HIV-associated kidney disease: the changing spectrum and treatment priorities	7
New and old approaches to nutritional management of acute and chronic glomerulonephritis	7
Editorial introduction	7
From K+ sensing to NCC on/off switching: KS-WNK1 as a spatial organizer of WNK signaling	7
Recent advances in treatment options for kidney disease	7
New regulators of parathyroid hormone secretion	7
Implications of the cystatin C/creatinine discordance	7
Enhancing accuracy and adherence in blood pressure monitoring in living kidney donation: implementing technologies to overcome challenges	6
Diagnosis and treatment of immune checkpoint inhibitor induced kidney disease	6
An update on the epidemiology of chronic kidney disease of uncertain etiology	6
Rare genetic disorders that impair parathyroid hormone synthesis, secretion, or bioactivity provide insights into the diagnostic utility of different parathyroid hormone assays	6
Proximal tubule responses to injury: interrogation by single-cell transcriptomics	6
Adverse effects during treatment with renin–angiotensin–aldosterone system inhibitors; should we stay or should we stop?	6
Exercise as a therapeutic intervention in chronic kidney disease: are we nearly there yet?	6
Fibroblast growth factor 23 at the crossroads of mineral metabolism and bone disease	6
Early changes in kidney function in young adults: what is the significance?	6
Prevention of postoperative acute kidney injury: insights from recent clinical trials	6
Editorial introductions	6
Vaccination in kidney disease: what did we learn from COVID-19 pandemic	6
Screening for chronic kidney disease: change of perspective and novel developments	6
Staff-assisted peritoneal dialysis in the United States: from evidence to national adoption	6
The changing trajectory of diabetic kidney disease	6
Targeting inflammation in hypertension	6
New guidelines and therapeutic updates for the management of lupus nephritis	6
Novel approaches in antihypertensive pharmacotherapeutics	6
Multimodal approaches for inequality in kidney care: turning social determinants of health into opportunities	6
New therapeutic perspectives for vascular and valvular calcifications in chronic kidney disease	6
Renal denervation: recent developments in clinical and preclinical research	6
Evolving indications and management patterns in heart – kidney transplantation	6
Systemic versus local regulation of vitamin D	6
Peritoneal dialysis and heart failure	6
Therapies in autosomal dominant polycystic kidney disease: beyond tolvaptan	6